Radicava: A Review of Clinical Trial Data and Drug Considerations from mgh Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 34 min 26 sec ✓ Published: 15-Mar-2018
Description: Radicava (edaravone) is a drug that was approved by the U.S. Food and Drug Administration (FDA) to treat people with ALS in May of 2017. Dr. Jonathan Glass, Emory University, opens the presentation with a summary of the clinical trial data that led to the FDA approval of Radicava, and Darlene Sawicki, Massachusetts General Hospital, discusses the pros and cons of choosing Radicava, as well as details about obtaining the drug.
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)